4//SEC Filing
NEWLINK GENETICS CORP 4
Accession 0001126234-14-000034
CIK 0001126234operating
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:33 PM ET
Size
10.6 KB
Accession
0001126234-14-000034
Insider Transaction Report
Form 4
NEWLINK GENETICS CORP(NLNK)
LINK GORDON H JR
Chief Financial Officer
Transactions
- Sale
Common Stock
2014-01-07$22.55/sh−453$10,215→ 14,213 total - Tax Payment
Common Stock
2014-01-07$22.55/sh−47$1,060→ 14,666 total - Exercise/Conversion
Stock Option (Right to Buy)
2014-01-07−500→ 65,239 totalExercise: $2.10Exp: 2018-08-05→ Common Stock (500 underlying) - Exercise/Conversion
Common Stock
2014-01-07$2.10/sh+500$1,050→ 14,713 total
Footnotes (4)
- [F1]Represents a "net exercise" of outstanding stock options. The reporting person received 453 shares of common stock on net exercise of option to purchase 500 shares of common stock. The Reporting Person forfeited 47 shares of common stock underlying the option in payment of the exercise price, using a weighted average stock price from the sale of $22.549.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.42 to $22.68, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote 2 to this Form 4.
- [F3]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on 7/29/2013.
- [F4]1/4th of the shares vest on August 4, 2009, which is one year after the vesting commencement date. 1/48th of the shares vest monthly thereafter over the next three years.
Documents
Issuer
NEWLINK GENETICS CORP
CIK 0001126234
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001126234
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 5:33 PM ET
- Size
- 10.6 KB